BioRestorative Therapies, Inc.
BRTX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001505497
No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in BioRestorative Therapies, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q1 2022
- Shares held
- 330.8K
- −14.0K (−4.1%) vs. Q1 2022
- Total value
- $975.1K
- −$827.1K (−45.9%) vs. Q1 2022
- New holders
- 1
- 6 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.00M |
| Q1 2026 | 14 | $184.2K |
| Q4 2025 | 16 | $383.4K |
| Q3 2025 | 17 | $550.3K |
| Q2 2025 | 18 | $413.9K |
| Q1 2025 | 17 | $501.8K |
| Q4 2024 | 17 | $405.6K |
| Q3 2024 | 17 | $471.9K |
| Q2 2024 | 15 | $520.0K |
| Q1 2024 | 15 | $531.0K |
| Q4 2023 | 15 | $540.9K |
| Q3 2023 | 15 | $648.7K |
| Q2 2023 | 14 | $1.42M |
| Q1 2023 | 17 | $1.02M |
| Q4 2022 | 18 | $900.4K |
| Q3 2022 | 19 | $1.16M |
| Q2 2022 | 16 | $975.1K |
| Q1 2022 | 17 | $1.80M |
| Q4 2021 | 13 | $1.72M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 2 | $12.0K |
| Q1 2021 | 1 | $30.0K |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding BioRestorative Therapies, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 135,046 | $398.0K | 0.00% | 00.0% | Unchanged |
| Ayrton Capital LLC | 61,418 | $181.0K | 0.29% | −16,344−21.0% | Reduced |
| Wealth Alliance | 44,316 | $131.0K | 0.03% | +4,316+10.8% | Added |
| Boothbay Fund Management, LLC | 32,000 | $94.0K | 0.00% | −8,000−20.0% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 23,000 | $68.0K | 0.00% | −10.0% | Reduced |
| StoneX Group Inc. | 14,954 | $44.1K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,313 | $36.0K | 0.00% | +1,404+12.9% | Added |
| Steward Partners Investment Advisory, LLC | 3,000 | $9.00K | 0.00% | +1,000+50.0% | Added |
| Tower Research Capital LLC (TRC) | 2,365 | $7.00K | 0.00% | +1,435+154.3% | Added |
| Advisor Group Holdings, Inc. | 1,694 | $5.00K | 0.00% | +1,694 | New |
| North Star Investment Management Corp. | 201 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 499 | $1.00K | 0.00% | +498+49,800.0% | Added |
| Wells Fargo & Company | 18 | $0 | 0.00% | +2+12.5% | Added |
| JJJ Advisors Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 2 | – | – | 00.0% | Unchanged |
| Morgan Stanley | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −13−100.0% | Sold out |